نتایج جستجو برای: chemoradiotherapy

تعداد نتایج: 9965  

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2005
C Haie-Meder B Fervers E Fondrinier M Haugh C Lhomme J P Guastalla

BACKGROUND In 1993 the French National Federation of Cancer Centres (FNCLCC) initiated the Standards, Options and Recommendations (SOR) project. This is a collaboration between the FNCLCC, the 20 French cancer centres, and specialists from French public universities, general hospitals and private clinics, and some specialists learned societies. The main objective is to develop clinical practice...

Journal: :Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 2010
Marcin Hetnał Krzysztof Małecki Magdalena Wolanin Stanisław Korzeniowski Tomasz Walasek

PURPOSE The aim of this study is to assess results of treatment, factors influencing prognosis with regard to causes of failure and treatment tolerance in patients with thymoma. MATERIAL AND METHODS Between 1966 and 2006, 63 patients with thymoma had been treated at the Centre of Oncology in Krakow. Patients were treated by means of different treatment modalities: surgery followed by radiothe...

2014
Nam Kwon Lee Dae Yong Kim Sun Young Kim Jae Hwan Oh Won Park Doo Ho Choi Taek-Keun Nam Kyung-Ja Lee

PURPOSE To evaluate the treatment outcomes of local excision following preoperative chemoradiotherapy in patients with locally advanced rectal cancer who have not undergone radical surgery for any reason. MATERIALS AND METHODS The data of 27 patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy followed by local excision were analyzed retrospectively. The p...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2015
P Mitchell N Thatcher M A Socinski E Wasilewska-Tesluk K Horwood A Szczesna C Martín Y Ragulin M Zukin C Helwig M Falk C Butts F A Shepherd

BACKGROUND Tecemotide is a MUC1-antigen-specific cancer immunotherapy. The phase III START study did not meet its primary end point but reported notable survival benefit with tecemotide versus placebo in an exploratory analysis of the predefined patient subgroup treated with concurrent chemoradiotherapy. Here, we attempted to gain further insight into the effects of tecemotide in START. PATIE...

2014
Motoko Yamaguchi Katsuyoshi Takata Tadashi Yoshino Naoki Ishizuka Masahiko Oguchi Yukio Kobayashi Yasushi Isobe Kenichi Ishizawa Nobuko Kubota Kuniaki Itoh Noriko Usui Kana Miyazaki Izumi Wasada Shigeo Nakamura Yoshihiro Matsuno Kazuo Oshimi Tomohiro Kinoshita Kunihiro Tsukasaki Kensei Tobinai

Concurrent chemoradiotherapy has become one of the standard management approaches for newly diagnosed localized nasal natural killer (NK)/T-cell lymphoma (NKTCL). Few data are available on the prognostic biomarkers of NKTCL among patients treated with concurrent chemoradiotherapy. To evaluate the prognostic significance of immunophenotypic biomarkers for patients treated with concurrent chemora...

Journal: :Nutricion hospitalaria 2015
Peng Pan Guangzhou Tao XinChen Sun

AIMS To evaluate the nutritional status of patients undergoing chemoradiotherapy for esophageal cancer using subjective global assessment (SGA) and association of prealbumin levels to nutritional status. METHODS A prospective study was performed on 154 patients with esophageal cancer who were treated with concurrent chemoradiotherapy at center of radiation oncology in Huai'an First People's H...

Journal: :The Lancet. Oncology 2007
Val Gebski Bryan Burmeister B Mark Smithers Kerwyn Foo John Zalcberg John Simes

BACKGROUND Resectable oesophageal cancer is often treated with surgery alone or with preoperative (neoadjuvant) chemoradiotherapy or chemotherapy. We aimed to clarify the benefits of neoadjuvant chemoradiotherapy or chemotherapy versus surgery alone by a meta-analysis of randomised trial data. METHODS Eligible trials were identified first from earlier published meta-analyses and systematic re...

Journal: :International forum of allergy & rhinology 2017
Mohemmed N Khan Neeraja Konuthula Arjun Parasher Eric M Genden Brett A Miles Satish Govindaraj Alfred M Iloreta

BACKGROUND Sinonasal undifferentiated carcinoma (SNUC) is a rare, aggressive malignancy of unknown etiology with a poor overall prognosis. Its relative rarity has made it difficult to determine the impact of different treatment modalities on survival. METHODS Retrospective study of cases in the National Cancer Data Base (NCDB). NCDB cases that were diagnosed as having SNUC between January 1, ...

Journal: :Acta Oncologica 2021

Standard treatment for stage II and III rectal cancer has long consisted of neoadjuvant long-course chemoradiotherapy (CRT) or short-course radiotherapy (SCRT) followed by total mesorectal excision...

2018
Felix J. Hüttner Pascal Probst Eva Kalkum Matthes Hackbusch Katrin Jensen Alexis Ulrich Markus W. Büchler Markus K. Diener

BACKGROUND Neoadjuvant (chemo-)radiation has proven to improve local control compared to surgery alone, but this improvement did not translate into better overall or disease-specific survival. The addition of oxaliplatin to fluoropyrimidine-based neoadjuvant chemoradiotherapy holds the potential of positively affecting survival in this context since it has been proven effective in the palliativ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید